Capital Growth Management LP Merck & Co., Inc. Transaction History

Capital Growth Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $8.35 Million - $9.46 Million	100,000 New	100,000 $9.12 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $4.93 Million - $5.61 Million	-70,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $4.44 Million - $6.15 Million	70,000 New	70,000 $5.39 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $9.31 Million - $10.5 Million	-120,000 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$76.08 - $82.93 $9.13 Million - $9.95 Million	120,000 New	120,000 $10.1 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Capital Growth Management LP, based on Form 13F filings with the SEC.

Stay updated on Capital Growth Management LP with notifications on news.